Is Galleri the future of cancer treatment? It's not that simple. The new research from the company, while promising, isn't ...

Add Yahoo as a preferred source to see more of our stories on Google. Grail's Galleri test screens for more than 50 different types of cancer from a single blood draw. (Getty Images) (Getty Images) If ...

Another challenge facing test designers is that early detection may not necessarily save lives. A crucial factor, and something that is still unknown about the new multi-cancer tests, is whether they ...

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease.

A blood test that screens for more than 50 cancers is correct in 62% of cases where it thinks people may have the disease, a study has found. The Galleri test, which can be given annually and is being ...

Blood tests are the most common way for health professionals to detect and diagnose a range of medical conditions. But can it ...

A blood test for more than 50 types of cancer could significantly boost early detection and speed up diagnosis, according to a new study. Made by U.S. pharmaceutical company Grail, the Galleri test ...

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. It should be noted that the Galleri test not currently ...

For asymptomatic people without known risks, the downsides and uncertainties of multi-cancer early detection testing could ...

If you could take a simple blood test that could detect multiple types of cancer while they’re still in an early and treatable stage, would you? For many, the answer would be a resounding yes.